ScholarWorks@Korea University College of Medicine: Kim, Nan Hee

Detailed Information

Kim, Nan Hee (김난희)

Ansan Hospital (Department of Endocrinology and Metabolism, Ansan Hospital)

Research Area

Tel 031-412-5952
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Diabetes mellitus:30||type 2 diabetes:14||Metabolic syndrome:13||insulin resistance:12||type 2:12||Inflammation:10||metabolic syndrome:10||Diabetes mellitus, type 2:10||Type 2 diabetes:9||Obesity:9||Practice guideline:8||Atherosclerosis:7||Hypoglycemic agents:7||VEGF:7||Korea:6||variability:6||diabetes mellitus:6||obesity:6||Type 2 diabetes mellitus:5||Insulin resistance:5||Creactive protein:5||Sarcopenia:5||diabetic nephropathy:5||Insulin:5||Mortality:4||Hypertension:4||Cardiovascular disease:4||dementia:4||Diabetic nephropathy:4||Dementia:4||adiponectin:4||Clinical practice guideline:4||pulse wave velocity:4||Prevalence:4||Blood pressure:4||Nonalcoholic fatty liver disease:4||body mass index:3||Glucose:3||Korea national health and nutrition examination survey:3||Diagnosis:3||ultrasonography:3||proteinuria:3||impaired glucose tolerance:3||sarcopenia:3||Albuminuria:3||Therapeutics:3||inflammation:3||Renal insufficiency:3||Valsartan:3||Heart failure:3||prevalence:3||Diabetic nephropathies:3||mortality:3||Pulse wave velocity:3||Alzheimer's disease:3||Arterial stiffness:3||Positron emission tomography:3||diabetes:3||Cohort studies:2||Nonalcoholic fatty liver disease:2||당뇨병:2||incidence:2||atherosclerosis:2||제1형 당뇨병:2||interleukin6:2||Sleep duration:2||leukocyte telomere length:2||gammaglutamyl transferase:2||Glycemic variability:2||Blood glucose:2||Oral hypoglycemic agents:2||brain atrophy:2||Diabetic kidney disease:2||Oxidative stress:2||microRNA:2||cardiovascular disease:2||cardiovascular mortality:2||Extracellular vesicle:2||Blood glucose selfmonitoring:2||myocardial infarction:2||Parkinson's disease:2||chronic kidney disease:2||nonalcoholic fatty liver disease:2||Life style:2||FTO polymorphism:2||Pheochromocytoma:2||coronary artery disease:2||older people:2||oral glucose tolerance test:2||osteoporosis:2||Thyroid neoplasms:2||dapagliflozin:2||positron emission tomography:2||Hepatokine:2||deep learning:2||Tie2:2||Adiponectin:2||Prediabetic state:2||risk factors:2||elderly:2||epidemiology:2||Dipeptidyl peptidaseIV inhibitors:2||estimated glomerular filtration rate:2||DM nephropathy:2||Menopause:2||Proteinuria:2||Visceral fat:2||stroke:2||Allcause mortality:2||Korean:2||Cardiovascular diseases:2||ER stress:2||Metformin:2||Efficacy:2||urine dipstick test:2||SWS study:2||vascular dementia:2||Insulin Resistance:2||visceral obesity:2||visfatin:2||Insulin resistance syndrome:2||Alzheimer disease:2||Diabetes:2||Glucose intolerance:2||AMPactivated protein kinase:2||Graves' disease:1||Gray matter:1||HDL:1||HEPATIC STEATOSIS:1||HIF1:1||HMGCoA reductase inhibitor:1||HbA1c:1||Heart rate:1||Hematologic parameters:1||Hemodynamics:1||Hemoglobin A, glycosylated:1||Highsensitivity Creactive protein:1||Hyperaldosteronism:1||Hyperfunction:1||Hyperparathyroidism:1||Hyperprolactinemia:1||Hypoglycemia:1||Hypokalemia:1||Hypopituitarism:1||Hypothyroidism:1||IgGtype autoantibody:1||Impaired glucose tolerance:1||Indians, North American:1||Intraabdominal fat:1||Intraoperative parathyroid hormone assay:1||Intraoperative parathyroid hormone level:1||Iodine:1||Jet lag syndrome:1||Kidney:1||Korea National Health and Nutrition Examination Survey VI:1||Korean National Health Insurance Corporation:1||Koreans:1||Lcarnitine:1||LDL:1||LDSD:1||LIPOAPOPTOSIS:1||Lasers:1||Left ventricular mass:1||Leptin:1||Leukocyte cellderived chemotaxin 2:1||Leukocytes:1||Lifestyle modification:1||Lipid profile:1||Lisinopril:1||Liver cirrhosis:1||Liver function tests:1||Low income:1||Low skeletal muscle mass:1||Lung neoplasms:1||MHO:1||Malignant pleural effusion:1||Mesangial cell:1||Metabolic health:1||Metabolic pathways:1||Metabolically abnormal but normal weight:1||Metabolically healthy but obese:1||Metabolite profiling:1||Metrnl:1||Mineralocorticoid receptor antagonists:1||Monotherapy:1||Muscle:1||Muscle strength:1||NacetylDGlucosaminidase:1||N/A:1||NAFLD:1||NMR:1||NONALCOHOLIC FATTY LIVER DISEASE:1||Neoplasm metastasis:1||Neovascularization:1||Nerve conduction study:1||Neurohypophysis:1||Nutrition surveys:1||Nuts:1||OLETF rat:1||Obesity in elderly:1||Obesity metabolism:1||Obstructive:1||Obstructive sleep apnea:1||Osteoporosis:1||Osteoporotic fractures:1||Pain:1||Papillary thyroid microcarcinoma:1||Paraganglioma:1||Parathyroid carcinoma:1||Parathyroid cyst:1||Paravertebral muscle:1||Peripheral artery disease:1||Phase III study:1||Phosphodiesterase inhibitor:1||Pituitary stalk:1||Point of care testing:1||Pooled cohort risk scores:1||Poorly differentiation攀접수일자: 2002년 2월 5일통과일자: 2002년 2월 25일:1||Posture:1||Primary progressive aphasia:1||Proinflammatory reactions:1||Product surveillance:1||Progression:1||QT interval:1||RAGE:1||REPUBLIC OF KOREA:1||Randomized controlled study:1||Rat:1||Renal function:1||Renin angiotensin system:1||Republic of Korea:1||Risk factors:1||SD Check Gold:1||SGLT2 inhibitor:1||SWS:1||Sarcopenic obesity:1||Sclerostin:1||Selenoprotein P:1||Self monitoring:1||Serum:1||Sesn2:1||Sestrin2:1||Signal pathway:1||Skeletal muscle:1||Skeletal muscle mass:1||Skeletal muscle mass index:1||Sleep:1||Sleep apnea:1||Sleep apnea, obstructive:1||Sleep deprivation:1||Smallfiber neuropathy:1||Sodium glucose transporter 2 inhibitors:1||Sodiumglucose cotransporter 2 inhibitor:1||Sodiumglucose transporter 2 inhibitors:1||South Korea:1||Statin:1||Stroke:1||Subclinical Atherosclerosis:1||Sulfonylurea:1||Surgery:1||Syndrome X:1||TGF betainducible gene h3(beta igh3):1||TGFβ:1||TNFa:1||TNFalpha:1||Telemedicine:1||Telmisartan:1||The Jolly Fat hypothesis:1||The Korean National Health Insurance Corporation:1||Thiazolidinediones:1||Thyroid:1||Thyroid cancer, papillary:1||Thyroid papillary carcinoma:1||Thyroidstimulating hormone:1||Tomography:1||Treatment:1||Treatment outcomes:1||Triglycerides:1||Type 1 diabetes:1||Type 2:1||Type 2 diabetic rats:1||Urine:1||Variability:1||Vascular adhesion molecules:1||Vascular inflammation:1||Visceral adiposity:1||Vitamin D:1||WHO 2h criteria:1||WHO criteria:1||Waisttohip ratio:1||Wessely and Powell score:1||Wnt pathway:1||Xray computed:1||abdominal:1||acutephase protein:1||adipocytokines:1||adiposity:1||adolescents:1||adrenocortical tumor:1||aging:1||albuminuria:1||alcohol:1||allodynia:1||angiopoietin:1||ankle brachial index:1||anklebrachial pressure index:1||anthropometric index:1||anthropometry:1||antithyroid drug:1||apolipoprotein B100:1||apoptosis:1||arsenic:1||arterial stiffness:1||aspergilloma:1||autoimmune type 1 diabetes mellitus:1||benign disease:1||big data:1||biological aging:1||blood pressure:1||body composition:1||body weight:1||bone density:1||bovine aortic endothelial cell:1||bovine retinal pericyte:1||cJun Nterminal kinase:1||cJun Nterminal kinases:1||cancer:1||cardiac risk factors and prevention:1||cardiovascular disease (CVD):1||carotid intima media thickness:1||carotid intimamedia thickness:1||central obesity:1||chest Xray:1||chronic:1||cognition:1||cognitive decline:1||congenital adrenal hyperplasia:1||convolutional neural network:1||crosssectional study:1||cutaneous neuroma:1||cytokine:1||cytokines:1||db/db mice:1||democratic people's republic of korea:1||depression:1||diabetes mellitus nephropathy:1||diabetes mellitus, type 2:1||dietary intervention:1||dosefinding study:1||dyslipidemia:1||echocardiography:1||ectopic adrenocorticotropic hormone syndrome:1||endstage kidney disease:1||epitope:1||esRAGE:1||estimation model:1||excisional biopsy:1||factor analysis:1||fasting plasma glucose:1||fatty liver disease:1||fenofibrate:1||ferritin:1||fetuinA:1||fineneedle aspiration:1||fracture:1||gammaglutamyltransferase:1||ghrelin:1||gingko:1||glucose tolerance:1||glucose variability:1||glycemic variability:1||gray matter:1||health disparity:1||heart failure:1||hemoglobin:1||hemoglobin (HbA1c) prediction:1||hepatic steatosis index:1||highfat diet induced obesity:1||highnormal blood pressure:1||highsensitivity Creactive protein:1||hypercortisolism:1||hyperglycaemia:1||hyperlipidemia:1||hypertension:1||hyperthyroidism:1||hypertriglyceridaemia:1||hypoxia:1||impaired fasting glucose:1||inching method:1||insulitis:1||interleukin 6:1||interleukin10:1||intermediate hyperglycemia:1||knee:1||left ventricle:1||left ventricular hypertrophy:1||lipid:1||liver steatosis:1||longitudinal:1||longitudinal study:1||low muscle mass:1||machine learning (ML):1||magnetic resonance imaging:1||melatonin:1||mesangial cells:1||metabolic diseases:1||metformin:1||microRNAs:1||microalbuminuria:1||mimotope:1||monotherapy:1||multivariate analysis:1||nested casecontrol studies:1||neuritis:1||night blood pressure:1||nonalcoholic fatty liver:1||nonobese:1||obese patients:1||obstructive sleep apnea:1||occupational health:1||older adults:1||omentin1:1||pain:1||paragangliomas:1||pheochromocytoma:1||pioglitazone:1||postmarketing:1||prehypertension:1||probucol:1||proinsulin:1||proinsulin/insulin ratio:1||proximal tubule cell:1||pulmonary carcinoid tumor:1||pulse wave:1||radioactive iodine treatment (RAI treatment):1||radioiodine ablation:1||randomized controlled trial:1||resistin:1||retrospective cohort study:1||rosiglitazone:1||sFLT1:1||screening tool:1||short sleep duration:1||sialic acid:1||sitagliptin:1||skeletal:1||skeletal muscle:1||skeletal muscle mass:1||sleep:1||sleep disordered breathing:1||smoking:1||socioeconomic status:1||sonography:1||streptozotocin:1||sulphonylureas:1||sural nerve:1||systemic inflammation:1||tea:1||teneligliptin:1||thyroglobulin:1||thyroid:1||thyroid cancer:1||thyroid tumor:1||total cholesterol:1||triple therapy:1||tumor necrosis factor alpha:1||type 2 diabetes mellitus:1||type 2 diabetesmellitus:1||urine sodiumcreatinine ratio:1||vascular:1||vascular endothelial cell growth factor:1||vascular endothelial growth factor:1||vascular inflammation:1||virtual reality and wearable EEG:1||vitamin D:1||waist circumference:1||weight loss:1||white blood cell count:1||zz:1||β cell dysfunction:1||갑상선 유두암:1||고중성지방혈증:1||다발성 부신경절종:1||당뇨병성 신증:1||당뇨병성 케톤산증:1||만성신질환:1||미토콘드리아 DNA 돌연변이:1||부신피질암:1||알부민뇨:1||제2형 당뇨병:1||진단:1||췌장소도 자가항체:1||치료:1||프로인슐린:1||2h PG:1||흉막전이:1||ADA:1||ADA fasting criteria:1||AMPK:1||ANGPTL3:1||ANGPTL8:1||Acute Myocardial Infarction:1||Acute phase protein:1||Adiposity:1||Adiposity in elderly:1||Adrenalectomy:1||Adrenocortical adenoma:1||Aged:1||Aldosterone receptor blocker:1||Alzheimer's dementia:1||Amlodipine:1||And mRNA:1||Angiopoietin:1||Angiotensin:1||Anthropometric index:1||Antipsychotic agents:1||Antisperm antibody:1||Apoptosis:1||Awareness:1||BCG:1||Biomarker:1||Body composition:1||Body fat composition:1||Body mass index:1||Body size phenotype:1||Body size phenotypes:1||Body temperature:1||Bone muscle interaction:1||Brain atrophy:1||BuddChiari syndrome:1||CHOP:1||COVID19:1||CRP:1||Carcinoma:1||Cardiocerebrovascular disease:1||Cardiometabolic risk factors:1||Cardiomyocytes:1||Cardiovascular benefit:1||Cardiovascular mortality:1||Casecontrol studies:1||Cellular phonne:1||Cervical recurrence:1||Chemerin:1||Chest multidetector computed tomography:1||Cholesterol:1||Chronic:1||Chronic kidney disease:1||Chronic renal disease:1||Cilostazol:1||Circadian clocks:1||Circadian rhythm:1||Circulating gene:1||Cognitive function:1||Cognitive impairment:1||Combination therapy:1||Community networks:1||Continuous glucose monitoring (CGM):1||Coronary artery calcification:1||Cushing syndrome:1||Cutaneous silent period:1||DHEA:1||DHEAS:1||DM:1||DPP4 inhibitor:1||DPPIV inhibitor:1||Delayed puberty:1||Dementia, vascular:1||Depressive symptoms:1||Diabetes complications:1||Diabetes mellitus:1||Diabetes mellitus Glucose variability:1||Diabetic polyneuropathy:1||Diabetic retinopathy:1||Diastole:1||Diastolic dysfunction:1||Diet:1||Differentiated thyroid cancer:1||Dipeptidyl peptidase4 inhibitor:1||Dipeptidyl peptidase4 inhibitors:1||Dipeptidylpeptidase IV inhibitors:1||Dyslipidemia, Korea:1||Dyslipidemias:1||ER STRESS:1||Echocardiography:1||Elderly:1||Elderly Koreans:1||Empagliflozin:1||Enavogliflozin:1||Endstage renal disease:1||Endothelial cells:1||Endothelial function:1||Endothelium:1||Epidemiology:1||Eplerenone:1||Estradiol:1||Expiratory dynamic tracheal collapse:1||F18fluorodeoxyglucose positron emission tomography:1||FGF21:1||Fasting blood glucose:1||Fasting plasma glucose:1||Fasting plasma glucose variability:1||Fatigue:1||Fatigue scale:1||Fatty liver:1||Finerenone:1||Fra1:1||Framingham risk score:1||Fulminant:1||Gender differences:1||Gene:1||Gene expression:1||Glucagonlike peptide 1:1||Glucagonlike peptide1 receptor agonist:1||Glucocorticoids:1||Glucose Intolerance:1||Glucose metabolism:1||Glycated hemoglobin A:1||Glycemic control:1||Glycosaminoglycan:1||GradCAM:1||

STATISTICS: Total View :12,651,741; Today View :5,678

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE